FDA Requires Vision Risk Warning on GLP-1 Drug Labels
Fact checked by NewsPlain
Brief
The Food and Drug Administration said Monday, Nov. 9, that all GLP-1 medicines must carry information about a potential risk of…
Keep reading with NewsPlain Premium
Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.
5 confirmed facts and 1 source behind this story.